Literature DB >> 28810165

Human immune system mouse models of Ebola virus infection.

Jessica R Spengler1, Joseph Prescott2, Heinz Feldmann2, Christina F Spiropoulou3.   

Abstract

Human immune system (HIS) mice, immunodeficient mice engrafted with human cells (with or without donor-matched tissue), offer a unique opportunity to study pathogens that cause disease predominantly or exclusively in humans. Several HIS mouse models have recently been used to study Ebola virus (EBOV) infection and disease. The results of these studies are encouraging and support further development and use of these models in Ebola research. HIS mice provide a small animal model to study EBOV isolates, investigate early viral interactions with human immune cells, screen vaccines and therapeutics that modulate the immune system, and investigate sequelae in survivors. Here we review existing models, discuss their use in pathogenesis studies and therapeutic screening, and highlight considerations for study design and analysis. Finally, we point out caveats to current models, and recommend future efforts for modeling EBOV infection in HIS mice. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28810165      PMCID: PMC5610641          DOI: 10.1016/j.coviro.2017.07.028

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  54 in total

1.  Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice.

Authors:  Deepika Rajesh; Ying Zhou; Ewa Jankowska-Gan; Drew Allan Roenneburg; Melanie L Dart; Jose Torrealba; William J Burlingham
Journal:  Hum Immunol       Date:  2010-03-26       Impact factor: 2.850

2.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

Authors:  Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

4.  Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.

Authors:  Jessica R Spengler; Kerry J Lavender; Cynthia Martellaro; Aaron Carmody; Andreas Kurth; James G Keck; Greg Saturday; Dana P Scott; Stuart T Nichol; Kim J Hasenkrug; Christina F Spiropoulou; Heinz Feldmann; Joseph Prescott
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

Review 5.  Human immune responses and potential for vaccine assessment in humanized mice.

Authors:  Ramesh Akkina
Journal:  Curr Opin Immunol       Date:  2013-04-27       Impact factor: 7.486

6.  Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.

Authors:  Eva Billerbeck; Walter T Barry; Kathy Mu; Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Blood       Date:  2011-01-20       Impact factor: 22.113

Review 7.  Of mice and not men: differences between mouse and human immunology.

Authors:  Javier Mestas; Christopher C W Hughes
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.

Authors:  Steven M Jones; Ute Stroher; Lisa Fernando; Xianggou Qiu; Judie Alimonti; Pasquale Melito; Mike Bray; Hans-Dieter Klenk; Heinz Feldmann
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

9.  Development and Characterization of a Guinea Pig-Adapted Sudan Virus.

Authors:  Gary Wong; Shihua He; Haiyan Wei; Andrea Kroeker; Jonathan Audet; Anders Leung; Todd Cutts; Jill Graham; Darwyn Kobasa; Carissa Embury-Hyatt; Gary P Kobinger; Xiangguo Qiu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 10.  Infectious diseases in humanized mice.

Authors:  Carol Leung; Obinna Chijioke; Cornelia Gujer; Bithi Chatterjee; Olga Antsiferova; Vanessa Landtwing; Donal McHugh; Ana Raykova; Christian Münz
Journal:  Eur J Immunol       Date:  2013-09       Impact factor: 5.532

View more
  11 in total

1.  Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.

Authors:  Jessica R Spengler; Greg Saturday; Kerry J Lavender; Cynthia Martellaro; James G Keck; Stuart T Nichol; Christina F Spiropoulou; Heinz Feldmann; Joseph Prescott
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

2.  Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice.

Authors:  Kerry J Lavender; Brandi N Williamson; Greg Saturday; Cynthia Martellaro; Amanda Griffin; Kim J Hasenkrug; Heinz Feldmann; Joseph Prescott
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

3.  When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Authors:  Jill M Pulley; Rebecca N Jerome; Nicole M Zaleski; Jana K Shirey-Rice; Andrea J Pruijssers; Robert R Lavieri; Somsundaram N Chettiar; Helen M Naylor; David M Aronoff; David A Edwards; Colleen M Niswender; Laura L Dugan; Leslie J Crofford; Gordon R Bernard; Kenneth J Holroyd
Journal:  Assay Drug Dev Technol       Date:  2017-12-01       Impact factor: 1.738

4.  Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.

Authors:  Zhengchen Su; Qing Chang; Aleksandra Drelich; Thomas Shelite; Barbara Judy; Yakun Liu; Jie Xiao; Changchen Zhou; Xi He; Yang Jin; Tais Saito; Shaojun Tang; Lynn Soong; Maki Wakamiya; Xiang Fang; Alexander Bukreyev; Thomas Ksiazek; William K Russell; Bin Gong
Journal:  PLoS Negl Trop Dis       Date:  2020-07-20

5.  Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.

Authors:  Jessica R Spengler; Anita K McElroy; Jessica R Harmon; JoAnn D Coleman-McCray; Stephen R Welch; James G Keck; Stuart T Nichol; Christina F Spiropoulou
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

Review 6.  A Review of Hearing Loss Associated with Zika, Ebola, and Lassa Fever.

Authors:  Samuel C Ficenec; John S Schieffelin; Susan D Emmett
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

Review 7.  Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection.

Authors:  Stephanie Longet; Jack Mellors; Miles W Carroll; Tom Tipton
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

8.  Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.

Authors:  Satoko Yamaoka; Hideki Ebihara
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

9.  Exchange Protein Directly Activated by cAMP Modulates Ebola Virus Uptake into Vascular Endothelial Cells.

Authors:  Aleksandra Drelich; Barbara Judy; Xi He; Qing Chang; Shangyi Yu; Xiang Li; Fanglin Lu; Maki Wakamiya; Vsevolod Popov; Jia Zhou; Thomas Ksiazek; Bin Gong
Journal:  Viruses       Date:  2018-10-16       Impact factor: 5.048

Review 10.  The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research.

Authors:  David M Wozniak; Kerry J Lavender; Joseph Prescott; Jessica R Spengler
Journal:  Vaccines (Basel)       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.